Edwards Lifesciences Corporation (FRA:EWL)
Germany flag Germany · Delayed Price · Currency is EUR
65.97
+0.51 (0.78%)
Last updated: Aug 14, 2025

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
Transcatheter Aortic Valve Replacement
4.11B
Log In
Log In
Log In
Log In
Upgrade
Transcatheter Aortic Valve Replacement Growth
6.28%
Log In
Log In
Log In
Log In
Upgrade
Surgical Structural Heart
981.30M
Log In
Log In
Log In
Log In
Upgrade
Surgical Structural Heart Growth
2.78%
Log In
Log In
Log In
Log In
Upgrade
Critical Care
-
Log In
Log In
Log In
Log In
Upgrade
Critical Care Growth
-
Log In
Log In
Log In
Log In
Upgrade
Transcatheter Mitral and Tricuspid Therapies
352.10M
Log In
Log In
Log In
Log In
Upgrade
Transcatheter Mitral and Tricuspid Therapies Growth
68.71%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
United States
3.21B
Log In
Log In
Log In
Log In
Upgrade
United States Growth
9.04%
Log In
Log In
Log In
Log In
Upgrade
Europe
1.32B
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
10.93%
Log In
Log In
Log In
Log In
Upgrade
Japan
339.80M
Log In
Log In
Log In
Log In
Upgrade
Japan Growth
0.50%
Log In
Log In
Log In
Log In
Upgrade
Rest of World
572.00M
Log In
Log In
Log In
Log In
Upgrade
Rest of World Growth
11.01%
Log In
Log In
Log In
Log In
Upgrade